# MediMorph — Dose conversions made easy

> Medical app for simplified narcotic dose conversions based on medical literature. (iPhone/iPad app by Ryan Vig.)

- Source: https://appshunter.io/ios/app/medimorph/id6479563936 (this page in markdown: same URL + `.md`)
- Developer: [Ryan Vig](https://appshunter.io/developer/1736336397)
- Category: Medical, Utilities
- Price: Free
- Rating: 5.00/5 from 3 App Store ratings
- Age rating: 12+
- Requires: iOS 17.0 · 4 MB
- Languages: English
- Released: 2024-04-26
- Data updated: 2026-06-05
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/medimorph/id6479563936/reviews.md

## What is MediMorph?

MediMorph performs dose conversions to make calculating equivalent doses between narcotics easy.

Performing dose conversions by hand can be inaccurate and tedious, so MediMorph aims to provide a simple fix to this issue by allowing you to perform dose conversions between common narcotics with a few easy taps. Conversions are based on the gold standard resource for opiate dosing "Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing" by Mary Lynn McPherson.

Features:
- Dose conversions between common narcotics
- Conversions for both PO (oral) and IV/SQ (intravenous/subcutaneous) administration (for applicable narcotics)
- Reduced dose calculation (medical literature recommends initial dose reduction of 25-50% when switching between opiates)
- Display of conversion steps used to perform calculation
- Local history of calculations performed
- Notes, references, and disclaimer

Feel free to reach out if you have any questions or feedback, and thanks for taking a look!

Disclaimer: All information contained in and produced by the MediMorph application is provided for educational purposes only. The dose conversions performed by our app are approximate based on published medical literature and do not account for individual patient variables. Information provided by the MediMorph application should not be used as a substitute for clinical judgement, and should not be the basis of any clinical decisions. When using our app, we recommend referencing relevant literature and double checking the work displayed in the calculations our app performs in order to make more informed judgements. If you are not a healthcare professional, we advise checking with an anesthesiologist before making medical decisions involving narcotic administration. See the "Notes and References" page of the app for more information on our methods and the medical literature used to inform the development of the MediMorph application.

## Key features

- Dose conversions for common narcotics
- PO and IV/SQ administration conversions
- Reduced dose calculation
- Display of conversion steps
- Local calculation history
- Notes and references


## Frequently asked questions about MediMorph

### What is MediMorph used for?

MediMorph is a medical application designed to simplify and expedite dose conversions between common narcotics. It aims to reduce the inaccuracies and tedium associated with manual calculations for both oral (PO) and intravenous/subcutaneous (IV/SQ) administrations.

### What medical literature is MediMorph based on?

The dose conversions performed by MediMorph are based on the gold standard resource for opiate dosing, "Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing" by Mary Lynn McPherson.

### Does MediMorph account for individual patient variables?

No, the dose conversions performed by MediMorph are approximate and based on published medical literature. The app's disclaimer emphasizes that the information should not be used as a substitute for clinical judgment and does not account for individual patient variables.

### Can MediMorph calculate reduced doses?

Yes, MediMorph includes a feature for reduced dose calculation. Medical literature often recommends an initial dose reduction of 25-50% when switching between opiates, and the app facilitates this calculation.

### Does MediMorph have ads?

No, MediMorph does not contain advertisements. The application is free to use and does not display any ads.

### What devices does MediMorph support?

MediMorph is available for iPhone and iPad devices. It was released on April 26, 2024, and its latest version is 1.1, updated on April 27, 2024.

### How is MediMorph rated by users?

MediMorph has received a perfect rating of 5.0 stars from 3 ratings, indicating a very positive user reception. This suggests users find the app accurate and helpful for its intended purpose.

### Is MediMorph suitable for all ages?

MediMorph is rated for ages 12 and up. While it is a medical tool, the age rating suggests it is appropriate for younger users who are learning about medical calculations or for general educational purposes.

## Version history (last 2 releases)

### 1.1 — 2024-04-27

We've fixed some minor visual bugs and updated the text input to make conversions easier to perform!

### 1.0 — 2024-04-26

No release notes.

## Apps similar to MediMorph

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [Hydroxychloroquine Calculator](https://appshunter.io/ios/app/hydroxychloroquine-calculator/id6738626567) | 5.0 (1) | $1.99 | Medical |
| [Pediatric Anesthesia Calc](https://appshunter.io/ios/app/pediatric-anesthesia-calc/id6741476240) | 5.0 (2) | $9.99 | Medical |
| [Intubating Monkey](https://appshunter.io/ios/app/intubating-monkey/id451367656) | 5.0 (2) | $1.99 | Medical |
| [EBMcalc Pulmonary](https://appshunter.io/ios/app/ebmcalc-pulmonary/id358056843) | 4.7 (3) | $4.99 | Medical |
| [Opioids Dosage Conversion](https://appshunter.io/ios/app/opioids-dosage-conversion/id382383903) | 4.3 (18) | Free | Medical |
| [BMC MAT Quick Start](https://appshunter.io/ios/app/bmc-mat-quick-start/id1524468581) | 5.0 (27) | Free | Medical |

## Related topics

[opioid conversion calculator](https://appshunter.io/ios/topics/opioid-conversion-calculator)

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-05.*